Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Utilisation of cardiac pacemakers over a 20-year period: Results from a nationwide pacemaker registry.

de Vries LM, Dijk WA, Hooijschuur CA, Leening MJ, Stricker BH, van Hemel NM.

Neth Heart J. 2017 Jan;25(1):47-55. doi: 10.1007/s12471-016-0880-0.

2.

Therapy for ventricular arrhythmias in structural heart disease: a multifaceted challenge.

Proietti R, Joza J, Essebag V.

J Physiol. 2016 May 1;594(9):2431-43. doi: 10.1113/JP270534. Epub 2016 Jan 27. Review. Erratum in: J Physiol. 2017 Mar 15;595(6):2201-2202.

3.

Complications from prophylactic replacement of cardiac implantable electronic device generators in response to United States Food and Drug Administration recall: A systematic review and meta-analysis.

Zeitler EP, Patel D, Hasselblad V, Sanders GD, Al-Khatib SM.

Heart Rhythm. 2015 Jul;12(7):1558-64. doi: 10.1016/j.hrthm.2015.04.003. Epub 2015 Apr 3. Review.

4.

Perspectives of patients with cardiovascular implantable electronic devices who received advisory warnings.

Ottenberg AL, Mueller LA, Mueller PS.

Heart Lung. 2013 Jan-Feb;42(1):59-64. doi: 10.1016/j.hrtlng.2012.09.007.

5.

"Add-on pacing lead": an effective and safe alternative to lead replacement in ICD pacing failure.

Kumar S, Moorthy N, Kapoor A.

Indian Heart J. 2012 Jul-Aug;64(4):420-2. doi: 10.1016/j.ihj.2012.06.012. Epub 2012 Jun 27.

6.

Implantable cardioverter-defibrillator FDA safety advisories: Impact on patient mortality and morbidity.

Sengupta J, Kendig AC, Goormastic M, Hwang ES, Ching EA, Chung R, Lindsay BD, Tchou PJ, Wilkoff BL, Niebauer MJ, Martin DO, Varma N, Wazni O, Saliba W, Kanj M, Bhargava M, Dresing T, Taigen T, Ingelmo C, Bassiouny M, Cronin EM, Wilsmore B, Rickard J, Chung MK.

Heart Rhythm. 2012 Oct;9(10):1619-26. doi: 10.1016/j.hrthm.2012.07.002. Epub 2012 Jul 3.

7.

Medical-device recalls in the UK and the device-regulation process: retrospective review of safety notices and alerts.

Heneghan C, Thompson M, Billingsley M, Cohen D.

BMJ Open. 2011 May 15;1(1):e000155. doi: 10.1136/bmjopen-2011-000155.

8.

Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory.

Guédon-Moreau L, Chevalier P, Marquié C, Kouakam C, Klug D, Lacroix D, Brigadeau F, Kacet S; ECOST trial Investigators.

Eur Heart J. 2010 Sep;31(18):2246-52. doi: 10.1093/eurheartj/ehq203. Epub 2010 Jun 30.

9.

Magnetic resonance imaging, pacemakers and implantable cardioverter-defibrillators: current situation and clinical perspective.

Götte MJ, Rüssel IK, de Roest GJ, Germans T, Veldkamp RF, Knaapen P, Allaart CP, van Rossum AC.

Neth Heart J. 2010 Jan;18(1):31-7.

10.

Formation of a national network for rapid response to device and lead advisories: The Canadian Heart Rhythm Society Device Advisory Committee.

Krahn AD, Simpson CS, Parkash R, Yee R, Champagne J, Healey JS, Cameron D, Thibault B, Mangat I, Tung S, Sterns L, Birnie DH, Exner DV, Sivakumaran S, Davies T, Coutu B, Crystal E, Wolfe K, Verma A, Stephenson EA, Sanatani S, Gow R, Connors S, Paredes FA, Turabian M, Kus T, Essebag V, Gardner M.

Can J Cardiol. 2009 Jul;25(7):403-5.

11.

Impact of implantable cardioverter-defibrillator recalls on patients' anxiety, depression, and quality of life.

Undavia M, Goldstein NE, Cohen P, Sinthawanarong K, Singson M, Bhutani D, Munson T, Gomes JA, Fischer A, Mehta D.

Pacing Clin Electrophysiol. 2008 Nov;31(11):1411-8. doi: 10.1111/j.1540-8159.2008.01204.x.

12.

Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis.

Zhan C, Baine WB, Sedrakyan A, Steiner C.

J Gen Intern Med. 2008 Jan;23 Suppl 1:13-9. doi: 10.1007/s11606-007-0392-0.

13.

Supplemental Content

Support Center